Concepedia

Author

Anna Nordenskjöld

Linköping UniversityORCID

Also Known As

A Nordenskjöld, A. Nordenskjöld, A.E. Nordenskjöld, Anna E. Nordenskjöld, Anna Nordenskjöld

20

Publications

676

Citations

8

H-Index

14

Concepts

All Affiliations

Linköping UniversitySödra Älvsborg HospitalKarolinska InstitutetSahlgrenska University HospitalKarolinska University Hospital
AN

About

Anna Nordenskjöld is an author at Linköping University specializing in medicine, radiation oncology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

62

2

Medicine

2

2

62

3

Obstetrics

1

1

29

4

Pathology

1

1

29

5

Surgical Oncology

1

1

33

Anna Nordenskjöld

×

8

Publications

661

Citations

8

H-Index

YearCitations

Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease

Bertil Lindahl, Tomasz Baron, David Erlinge,

Circulation

2017

455

Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up

Chaido Chamalidou, Helena Fohlin, Per Albertsson,

The Breast

2021

41

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer

Anna Nordenskjöld, Helena Fohlin, Tommy� Fornander,

Breast Cancer Research and Treatment

2016

40

No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study

Anna Nordenskjöld, Helena Fohlin, Per Albertsson,

Annals of Oncology

2015

33

Breast cancer survival trends in different stages and age groups – a population-based study 1989–2013

Anna Nordenskjöld, Helena Fohlin, Lars G. Arnesson,

Acta Oncologica

2018

29

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

Annelie Johansson, Huma Dar, Laura van ‘t Veer,

Journal of Clinical Oncology

2022

29

Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/<i>ERBB2</i>-Negative Breast Cancer Treated With and Without Tamoxifen Therapy

Huma Dar, Annelie Johansson, Anna Nordenskjöld,

JAMA Network Open

2021

23

Proprotein convertase subtilisin/kexin type 9 and mortality in patients starting hemodialysis

Towe Strålberg, Anna Nordenskjöld, Yang Cao,

European Journal of Clinical Investigation

2019

11

Page 1